On Saturday May 5 at the American Psychiatric Association meeting, Mayo Clinic Health System psychiatrist Mohit Chauhan, M.D., gave an update on the Mayo Clinic Bipolar Disorder Biobank. Biobanks are a repository used to store human biological samples for use in research of genomics and personalized medicine – in this case gathering data to better treat patients with bipolar disorder.
The potential use for the Bipolar Biobank is twofold: The first is identify what types of genes make people more susceptible to bipolar disorder; and the second is learn which type of medications are more likely to work for an individual based on their genetic mapping.
Researchers are establishing this large-scale biobank of Bipolar Type I and II Disorder, collecting both biologic samples and clinical data from 2,000 individuals ages 18-80. Dr. Chauhan believes the information being collected from the bank will be extremely useful in treating patients in the coming years.